Mavik and dyspnoea 
Mavik and dyspnoea Patient Reports February 11, 2012
Mavik Side Effects Report #5709329-8
Mavik side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2008. Male patient, weighting 182.2 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: atrial fibrillation
, coronary artery disease , dyspnoea. Mavik dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ATORVASTATIN CALCIUM, AMIODARONE. Patient was hospitalized. Patient recovered.Mavik Side Effects Report #5872872-5
Mavik side effect was reported by a Consumer or non-health professional from CANADA on Aug 29, 2008. Male patient, weighting 182.2 lb, was diagnosed with hypertension and was treated with Mavik. After drug was administered, patient experienced the following side effects: atrial fibrillation
, chest discomfort, coronary artery disease , dyspnoea. Mavik dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, ATORVASTATIN CALCIUM, AMIODARONE. Patient was hospitalized. Patient recovered.Mavik Side Effects Report #4571384-9
Mavik side effect was reported by a Consumer or non-health professional from on Jan 27, 2005. Female patient, weighting 165.1 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Mavik. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, superinfection lung, supraventricular tachycardia. Mavik dosage: unknown. During the same period patient was treated with GLICLAZIDE, ROSIGLITAZONE MALEATE, METFORMIN. Patient was hospitalized. Patient recovered.
Mavik Side Effects Report #4588250-5
Mavik side effect was reported by a Consumer or non-health professional from on Jan 27, 2005. Female patient, weighting 165.1 lb, was diagnosed with hypertension, diabetes mellitus, cardiac failure, insomnia, supraventricular tachycardia, chronic obstructive pulmonary disease and was treated with Mavik. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, superinfection lung, supraventricular tachycardia. Mavik dosage: unknown. During the same period patient was treated with GLICLAZIDE, ROSIGLITAZONE MALEATE, METFORMIN, FUROSEMIDE, LORAZEPAM, DILTIAZEM HYDROCHLORIDE, COMBIVENT, FLUTICASONE PROPIONATE. Patient was hospitalized. Patient recovered.